Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in NAFLD and NASH (PRONE)
NCT04175392Phase 2Terminated
- Sponsor
- Corewell Health
- Start
- Jan 2021
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Corewell Health. Primary endpoint: Probiotic Effects on Liver Fibrosis at 6 months. Started Jan 2021; status: terminated.
Beyond the preview
Go deeper on NCT04175392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04175392.